Everything Vets Need to Know About PGCL Suture Absorption Time

Among the absorbable surgical suture options available in veterinary practice, PGCL occupies a distinct and clinically valuable position. It sits between the shorter absorption profile of PGA and the extended timeline of PDS, offering a combination of monofilament infection resistance, flexible handling, and predictable mid-term absorption that suits a range of internal soft tissue applications. For veterinary professionals selecting sutures for urogenital procedures, laparoscopic surgery, subcutaneous closure, and contamination-sensitive environments, understanding the full clinical profile of PGCL is practical knowledge that directly influences patient outcomes.

 

What Is PGCL?

 

PGCL stands for Polyglycolide-co-Caprolactone, produced from two monomers: glycolide and ε-caprolactone. The glycolide component contributes tensile strength and controls the degradation rate through hydrolysis. The ε-caprolactone component introduces flexibility and pliability that improves handling compared to more rigid monofilament materials such as PDS.

The result is a monofilament absorbable surgical suture with a single continuous strand, a smooth non-porous surface, and handling characteristics that are noticeably more pliable than PDS monofilament while still maintaining the infection resistance that defines all monofilament suture structures. In veterinary practice, PGCL is most commonly used in clean internal closures where both extended absorption and monofilament properties are clinically relevant.

 

PGCL Suture Absorption Time

 

The PGCL suture absorption time is 90 to 120 days from implantation. Degradation occurs through hydrolysis, the same mechanism that governs all synthetic absorbable veterinary sutures. Water molecules penetrate the polymer matrix and gradually cleave the ester bonds within the glycolide and caprolactone chains, breaking the material into progressively smaller fragments that are then metabolized and excreted by the animal's body.

Because PGCL degrades through hydrolysis rather than enzymatic activity, its absorption timeline is not significantly affected by local tissue inflammation, infection, or individual variation in patient physiology. This predictability is one of the defining advantages of synthetic absorbable sutures over natural alternatives such as Chromic Catgut, where enzymatic degradation can vary considerably between patients and tissue environments.

The 90 to 120 day PGCL suture absorption time positions it between PGA at 60 to 90 days and PDS at 180 to 210 days. This mid-to-extended window suits tissue layers requiring longer mechanical support than PGA can offer while not requiring the full long-duration profile of PDS. When the clinical requirement is extended internal support with monofilament infection resistance, PGCL fits that need precisely.

For a broader comparison of how absorption timelines differ across the main absorbable veterinary sutures, see Understanding How Absorbable Sutures Work and How Long They Last.

 

Tensile Strength Retention Over Time

 

Understanding PGCL suture absorption time requires looking at how tensile strength evolves throughout that period, not just when complete absorption is achieved. Tensile strength and absorption time are not the same measurement. A suture can retain clinically useful mechanical support for a substantial portion of its absorption period well before the final degradation of remaining polymer fragments is complete.

PGCL maintains approximately 50 percent of its initial tensile strength at two weeks after implantation. This level of retention covers the transition from the proliferative phase of healing into the early remodeling phase, which is the period during which wound dehiscence risk is highest in most internal closure sites.

Strength declines progressively after two weeks as hydrolysis advances through the polymer matrix. The gradual nature of this decline ensures that the wound is never subjected to a sudden loss of mechanical support. The suture weakens in parallel with the tissue's own strengthening through collagen synthesis and maturation, supporting a smooth transfer of mechanical load from the suture to the healing tissue.

By the end of the 90 to 120 day PGCL suture absorption time, the polymer fragments have been fully metabolized and the suture has disappeared entirely from tissue, leaving no residual foreign material to stimulate chronic inflammation or granuloma formation.

This profile makes PGCL particularly appropriate for tissue layers that require more than the four to six week functional window of PGA but do not need the twelve-week-plus retention of PDS. For a detailed discussion of how each absorbable material's strength profile maps onto specific tissue healing requirements, see Role of Absorbable Sutures in Veterinary Soft Tissue Surgery Healing.

 

Why the Monofilament Structure of PGCL Matters Clinically

 

PGCL is produced as a monofilament, and this structural characteristic carries clinical consequences that are as important as the absorption timeline for many of its primary applications.

A monofilament suture presents a single smooth strand to the surrounding tissue. There are no interstices between braided filaments where bacteria can colonize, no capillary channels along which bacteria from the wound surface can wick into deeper tissue planes, and no rough surface that generates additional mechanical trauma during placement. These properties make PGCL monofilament the preferred absorbable surgical suture in situations where infection control is a primary concern.

Urogenital surgery operates in an environment with an inherent bacterial load. The bladder, urethra, and associated structures are colonized with organisms in many patients, and suture material in these locations is exposed to a microbiologically challenging environment throughout the healing period. The non-wicking surface of a PGCL monofilament limits the risk of bacterial migration along the suture strand compared to braided materials such as PGA.

Gastrointestinal surgery shares this concern. The luminal contents of the GI tract contain significant bacterial populations. A suture that resists bacterial colonization along its surface supports a cleaner healing environment at the anastomosis site than a braided alternative would in comparable conditions.

Contaminated or potentially contaminated wounds across any anatomical site benefit from monofilament suture selection for the same reason. When the tissue environment cannot be guaranteed clean, eliminating a potential route of bacterial migration reduces the risk of post-operative infection.

For a detailed explanation of how monofilament structure reduces infection risk at the tissue level, see The Advantage of Monofilament Suture for Reducing Infection Risk.

 

How PGCL Performs Across Wound Healing Stages

 

Matching PGCL's tensile strength profile to the wound healing stages it must support explains why the 90 to 120 day absorption time suits specific tissue types so well.

During the inflammatory phase in days one to five, the suture provides the full mechanical load of the closure. Tissue has almost no native tensile strength at this point, and the integrity of the wound depends entirely on the suture material. PGCL's initial tensile strength provides reliable support through this critical period.

During the proliferative phase from approximately day five to fourteen, fibroblasts produce collagen and the wound begins to develop its own structural integrity. PGCL's approximately 50 percent strength retention at two weeks means it continues to provide meaningful closure support through the full proliferative phase, covering the transition into early remodeling when dehiscence risk remains elevated.

During the remodeling phase from week two onward, collagen matures and the tissue progressively approaches its final mechanical strength. For moderate-healing tissue layers such as subcutaneous tissue, fascial planes in clean presentations, and urogenital structures, the remodeling phase is sufficiently advanced within two to four months that PGCL's 90 to 120 day absorption window provides appropriate coverage without leaving foreign material in the wound longer than necessary.

Understanding how these healing phases interact with suture performance is central to informed veterinary suture selection. For a broader discussion of this relationship, see How Veterinary Suture Material Impacts Surgical Outcomes in Animals.

 

Clinical Applications of PGCL in Veterinary Soft Tissue Surgery

 

The combination of the 90 to 120 day PGCL suture absorption time and monofilament infection resistance defines the procedures where PGCL delivers its most consistent results in veterinary soft tissue surgery.

Urogenital surgery is one of the primary applications for PGCL in small animal practice. Cystotomy, urethrostomy, and urogenital reconstructive procedures require a suture that maintains reliable tensile strength through the healing period of bladder and urethral tissue while resisting the bacterial colonization that the urogenital environment presents. PGCL addresses both requirements with a single material choice.

Subcutaneous closure in infection-sensitive cases benefits from PGCL when contamination is a concern at this tissue level. For routine subcutaneous closure in clean surgical fields, braided PGA remains a practical and common choice. In cases where contamination risk is elevated, PGCL monofilament is the more appropriate selection.

Laparoscopic and minimally invasive procedures use PGCL because the smooth monofilament surface passes through laparoscopic access points and delicate internal tissue planes with minimal drag. The reduced tissue trauma of the monofilament structure is a genuine advantage in procedures where tissue handling is limited by access constraints.

Internal soft tissue closures in compromised patients represent another context where PGCL is particularly valuable. Older animals, immunocompromised patients, and animals presenting with pre-existing infection or systemic illness are at elevated risk for post-operative wound infection. Using a monofilament absorbable suture in these patients reduces one of the modifiable contributors to this risk.

General soft tissue repair where the surgeon prefers monofilament handling throughout the closure is a broad and common application. PGCL's greater flexibility compared to PDS monofilament makes it more approachable for surgeons who find monofilament handling outside their usual practice.

For a broader framework on matching absorbable sutures to each tissue layer and procedure type, see How to Select the Best Deep Tissue Suture for Veterinary Surgery.

 

 

Handling Properties of PGCL

 

PGCL is more pliable than PDS monofilament. The incorporation of ε-caprolactone into the copolymer introduces flexibility that reduces the memory effect characteristic of all monofilament sutures. Memory is the tendency of a monofilament to retain its coiled shape from packaging and spring back when tension is released. PGCL's greater inherent pliability means the memory effect is somewhat reduced compared to PDS, though still present and requiring additional throws for reliable knot security.

Four to five throws are standard when tying PGCL sutures to prevent slippage under physiological tension. This is consistent with all monofilament absorbable sutures and should be part of standard technique rather than treated as a limitation. The knot security achieved with appropriate throws is reliable and sufficient for all the applications where PGCL is clinically indicated.

The smooth monofilament passage through tissue reduces tissue drag at the needle passage site, creates a cleaner entry point, limits mechanical trauma to the surrounding tissue, and supports a more efficient closure workflow. For surgeons transitioning from braided to monofilament materials for internal closures, this handling quality is one of the practical advantages noticed most readily in practice.

For a comprehensive comparison of how monofilament handling properties compare to multifilament alternatives, see How Monofilament vs Multifilament Suture Performs in Veterinary Procedures.

 

How PGCL Compares to Other Absorbable Veterinary Sutures

 

Understanding where PGCL sits in relation to other absorbable materials helps veterinary professionals make clear selection decisions based on clinical requirements.

 

 

For a comprehensive guide to suture selection across the full range of veterinary procedures, see Complete Guide to Choosing Veterinary Surgical Sutures for Your Practice.

 

Factors That Can Influence PGCL Absorption Rate

 

While the 90 to 120 day PGCL suture absorption time is a reliable clinical reference, several patient and tissue factors can influence the rate of hydrolytic degradation within this range.

Tissue vascularity plays a role because well-vascularized tissue has greater access to water and the metabolic pathways that handle degradation byproducts. Tissue with rich blood supply tends to support faster absorption than poorly vascularized areas such as distal limbs or scar tissue.

Patient age and systemic health can affect metabolic rate and therefore the handling of degradation fragments. Young healthy animals tend to process degradation products efficiently. Older patients or those with systemic illness may have slightly slower metabolic clearance of absorbed material.

Local wound environment influences hydrolysis mildly. Tissues with elevated temperature or slightly acidic pH, as may be seen in the context of healing inflammation, can modestly accelerate hydrolysis. Significant deviation from the expected timeline typically reflects a change in wound condition worth clinical attention rather than a normal biological variable.

None of these factors are likely to shift PGCL absorption substantially outside the 90 to 120 day window in most clinical presentations, but awareness of them supports informed monitoring and accurate post-operative expectations for individual patients.

 

Choosing the Right Size PGCL for Each Application

 

Correct suture size selection is as important as material selection in achieving reliable internal closures. For PGCL in veterinary soft tissue surgery, size selection follows the same principle that governs all internal tissue closures: use the finest gauge that reliably meets the mechanical demands of the tissue layer and patient size.

For urogenital closures in cats and small dogs, sizes 4-0 and 3-0 are appropriate for bladder and urethral tissue where a fine gauge reduces tissue trauma at the closure site. For subcutaneous closure, sizes 3-0 and 2-0 suit most small to medium animal patients depending on the depth of the layer being closed. For fascial layers in infection-sensitive cases where PGCL is chosen over PGA, size 2-0 or 0 is appropriate based on patient size and tissue tension.

For detailed guidance on suture size selection across tissue layers and patient categories, see How to Choose Suture Size Based on Tissue Type and Procedure.

 

Key Takeaways 

 

PGCL suture absorption time of 90 to 120 days, combined with the monofilament infection resistance and improved flexibility of its copolymer structure, defines a distinct and practical clinical profile among absorbable veterinary sutures. For veterinary soft tissue surgery applications where contamination risk, monofilament handling, and mid-to-extended absorption are the governing clinical requirements, PGCL delivers consistent and reliable performance that neither shorter-absorption braided sutures nor longer-duration monofilaments can fully replicate.

MONOFIL® PGCL sutures are available through Gexfix International Corp., in partnership with Assut Europe S.P.A., alongside a full range of absorbable veterinary sutures including ASSUFIL® PGA, ASSUFIL® PDS monofilament, ASSUCROM® Chromic Catgut, ASSUNYL® Nylon, and FILBLOC® Barbed Sutures. With over 30 years of manufacturing expertise and ISO 13485-certified production standards, Gexfix supports veterinary practices with the reliable suture materials that consistent surgical outcomes require.

Explore the full range at medicaldevicevet.com.

 

FAQs

 

Q: What is the PGCL suture absorption time in veterinary patients?

A: PGCL sutures absorb completely over 90 to 120 days from implantation through hydrolysis. This places the absorption timeline between PGA at 60 to 90 days and PDS at 180 to 210 days, making PGCL appropriate for tissue layers requiring mid-to-extended internal support after veterinary soft tissue surgery.

Q: How long does PGCL retain tensile strength after implantation?

A: PGCL retains approximately 50 percent of initial tensile strength at two weeks after implantation. Strength declines progressively as hydrolysis advances, providing coverage through the proliferative and early remodeling phases before complete absorption is achieved between 90 and 120 days.

Q: Why is PGCL preferred over PGA in contaminated wound environments?

 

A: PGCL is a monofilament absorbable surgical suture with a smooth non-porous surface that resists bacterial colonization and capillary wicking along the suture strand. PGA is a braided suture with interstices between filaments where bacteria can harbor. In contaminated tissue environments the monofilament structure of PGCL provides a meaningful infection control advantage.

Q: What is the difference between PGCL and PDS for veterinary soft tissue surgery?

A: PGCL absorbs in 90 to 120 days and suits tissue layers with moderate healing timelines where monofilament infection resistance is a priority. PDS absorbs in 180 to 210 days and provides sustained tensile retention through twelve weeks for slow-healing high-tension structures such as body wall and fascia. Each material suits different tissue layers within the same surgical approach.

Q: Can PGCL be used for laparoscopic surgery in veterinary patients?

 A: Yes. PGCL's smooth monofilament surface passes through laparoscopic access points and delicate internal tissue planes with minimal drag, reducing mechanical trauma during placement. Its 90 to 120 day absorption timeline and low tissue reactivity make it a practical absorbable surgical suture for minimally invasive veterinary procedures.